ChromaDex Corporation (CDXC): Price and Financial Metrics

CDXC POWR Grades

• Quality is the dimension where CDXC ranks best; there it ranks ahead of 64.95% of US stocks.
• The strongest trend for CDXC is in Sentiment, which has been heading down over the past 48 weeks.
• CDXC's current lowest rank is in the Sentiment metric (where it is better than 23.82% of US stocks).

CDXC Stock Summary

• With a one year PEG ratio of 233, ChromaDex Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 88.05% of US stocks.
• For CDXC, its debt to operating expenses ratio is greater than that reported by just 9.92% of US equities we're observing.
• With a year-over-year growth in debt of 166.92%, ChromaDex Corp's debt growth rate surpasses 94.49% of about US stocks.
• Stocks that are quantitatively similar to CDXC, based on their financial statements, market capitalization, and price volatility, are HAYN, HROW, NAOV, SREV, and KRKR.
• Visit CDXC's SEC page to see the company's official filings. To visit the company's web site, go to www.chromadex.com.

CDXC Valuation Summary

• In comparison to the median Healthcare stock, CDXC's price/sales ratio is 17.18% lower, now standing at 9.4.
• Over the past 150 months, CDXC's EV/EBIT ratio has gone down 20.7.
• Over the past 150 months, CDXC's price/earnings ratio has gone down 21.9.

Below are key valuation metrics over time for CDXC.

CDXC Growth Metrics

• The 5 year net cashflow from operations growth rate now stands at -1404.16%.
• Its 3 year cash and equivalents growth rate is now at 532.79%.
• The 5 year revenue growth rate now stands at 131.07%.

Over the past 33 months, CDXC's revenue has gone up $31,986,164.

The table below shows CDXC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	62.007	-17.123	-23.259
2021-03-31	59.595	-10.784	-21.404
2020-12-31	59.257	-10.6	-19.925
2020-09-30	56.901	-11.232	-22.681
2020-06-30	54.774	-15.147	-25.668
2020-03-31	50.588	-22.612	-29.712

CDXC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CDXC has a Quality Grade of C, ranking ahead of 64.95% of graded US stocks.
• CDXC's asset turnover comes in at 1.178 -- ranking 15th of 677 Pharmaceutical Products stocks.
• CEMI, MYGN, and NEOG are the stocks whose asset turnover ratios are most correlated with CDXC.

The table below shows CDXC's key quality metrics over time.